In some cases, genetic diagnosis modifies the treatment plan, like in a female who presented with neonatal epileptic encephalopathy, and we identified a de novo variant in the SCN2A gene which resulted in modifying the therapy to a ketogenic diet with good response. This evidence concerns the gene SCN2A and Epileptic encephalopathy.